Patents by Inventor Nigel James

Nigel James has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Herbicidal compounds
    Patent number: 8987455
    Abstract: The present invention relates to a method of controlling plants or inhibiting plant growth which comprises applying to the plants or to the locus thereof a herbicidally effective amount of a compound of formula (I) wherein A1, A2, A3, A4, R3, R4 and R5 are as defined in claim 1; or a salt or N-oxide thereof. Furthermore, the present invention relates to processes for preparing compounds of formula (I), to intermediates used in the preparation of compounds of formula (I), to herbicidal compositions comprising compounds of formula (I) and to certain novel pyridopyridines, pyridodiazines and pyridotriazines.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: March 24, 2015
    Assignee: Syngenta Limited
    Inventors: Matthew Robert Cordingley, Michael Drysdale Turnbull, Nigel James Willetts, Patrick Jelf Crowley
  • Herbicidal 5H-quinoxaline-6-one derivatives detailed description
    Patent number: 8962628
    Abstract: The present invention provides a compound of formula (I) wherein R4 is of sub-formula (a) or (b) and wherein the other substituents are as defined in the specification. The compounds of formula (I) are potentially useful as herbicides.
    Type: Grant
    Filed: October 14, 2011
    Date of Patent: February 24, 2015
    Assignee: Syngenta Limited
    Inventors: Alaric James Avery, Alain De Mesmaeker, Nicholas Phillip Mulholland, Nigel James Willetts, Paul Anthony Worthington
  • METHOD OF MARINE TRANSPORTATION OF UNSWEETENED NATURAL GAS
    Publication number: 20140345299
    Abstract: Marine transportation of natural gas is disclosed, including: a) removing a free water stream and a condensate stream from the source of raw natural gas to produce a dew-pointed unsweetened natural gas stream at an offshore supply location; b) subjecting the dew-pointed unsweetened natural gas stream to a selected level of dehydration to produce a partially dehydrated unsweetened natural gas stream at the offshore supply location; and c) transporting at least a portion of the partially dehydrated unsweetened natural gas stream in a gas containment system onboard a gas carrier vessel from the offshore supply location as a feed source of natural gas to an acid gas removal facility or an LNG production facility located at an offloading location.
    Type: Application
    Filed: September 17, 2012
    Publication date: November 27, 2014
    Inventors: David Kirk, Adrian Armstrong Macmillan, Nigel James Palmer
  • System and method for analyzing data
    Patent number: 8849638
    Abstract: A computer-implemented method, computer program product, and computing system for obtaining an oil field modeling file. One or more values are associated with one or more variables included within the oil field modeling file. The oil field modeling file is executed to generate one or more result sets. A portion of each of the one or more result sets is compared with empirically-derived data related to the portion.
    Type: Grant
    Filed: August 10, 2010
    Date of Patent: September 30, 2014
    Assignee: X Systems, LLC
    Inventors: Nigel James Brock, Geoffrey John George Wilby
  • Novel Polymorphs and Salts
    Publication number: 20140256721
    Abstract: The present invention is directed to novel polymorphs and salts of a compound which is an inhibitor of kinase activity.
    Type: Application
    Filed: April 14, 2014
    Publication date: September 11, 2014
    Applicant: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Charlotte Jane Mitchell, Nigel James Parr, Robert David Willacy
  • Vacuum pumping systems
    Patent number: 8793007
    Abstract: The present invention relates to a vacuum pumping system (10) which comprises: a vacuum pumping mechanism (12) and a motor (14) for driving the vacuum pumping mechanism. Means (16) are provided for determining a cumulative load on the vacuum pumping system over time by monitoring a characteristic of the motor over that time. Means (18) are also provided for activating a maintenance activity on the system when the cumulative load exceeds a predetermined amount.
    Type: Grant
    Filed: June 2, 2009
    Date of Patent: July 29, 2014
    Assignee: Edwards Limited
    Inventors: Laurent Marc Philippe, Nigel James Gibbins, Michael Roger Czerniak, Michael Mooney
  • Compounds
    Patent number: 8765743
    Abstract: The invention is directed to compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: July 1, 2014
    Assignee: Glaxosmithkline Intellectual Property Development Limited
    Inventors: Ian Robert Baldwin, Kenneth David Down, Paul Faulder, Simon Gaines, Julie Nicole Hamblin, Joelle Le, Christopher James Lunniss, Nigel James Parr, Timothy John Ritchie, Juliet Kay Simpson, Christian Alan Paul Smethurst
  • Polymorphs and salts
    Patent number: 8735390
    Abstract: The present invention is directed to novel polymorphs and salts of a compound which is an inhibitor of kinase activity.
    Type: Grant
    Filed: September 6, 2011
    Date of Patent: May 27, 2014
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Charlotte Jane Mitchell, Nigel James Parr, Robert David Willacy
  • Compounds which selectively modulate the CB2 receptor
    Patent number: 8735430
    Abstract: Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: May 27, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Alessandra Bartolozzi, Eugene Richard Hickey, Doris Riether, Lifen Wu, Renee M. Zindell, Nigel James Blumire, Monika Ermann, Edward Thomas Glenn, Someina Khor, Przemyslaw Zawadzki
  • Vaccine Against African Horse Sickness Virus
    Publication number: 20140120133
    Abstract: The present invention provides vectors that contain and express in vivo the genes encoding VP2 and VP5 of African Horse Sickness Virus or an epitope thereof that elicits an immune response in a horse against African horse sickness virus, compositions comprising said vectors, methods of vaccination against African horse sickness virus, and kits for use with such methods and compositions.
    Type: Application
    Filed: October 22, 2013
    Publication date: May 1, 2014
    Applicants: MERIAL LIMITED, UNIVERSITY OF PRETORIA, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Jules Maarten Minke, Jean Christophe Audonnet, Alan John Guthrie, Nigel James Maclachlan, Jiansheng Yao
  • Novel Compounds
    Publication number: 20140080830
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): And salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Application
    Filed: November 25, 2013
    Publication date: March 20, 2014
    Applicant: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Charlotte Jane Mitchell, Nigel James Parr
  • Benzpyrazol derivatives as inhibitors of PI3 kinases
    Patent number: 8658635
    Abstract: The invention is directed to certain novel compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: February 25, 2014
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Ian Robert Baldwin, Kenneth David Down, Paul Faulder, Simon Gaines, Julie Nicole Hamblin, Joelle Le, Christopher James Lunniss, Nigel James Parr, Timothy John Ritchie, John Edward Robinson, Juliet Kay Simpson, Christian Alan Paul Smethurst
  • HERBICIDAL COMPOUNDS
    Publication number: 20140011677
    Abstract: The present invention relates to a method of controlling plants or inhibiting plant growth which comprises applying to the plants or to the locus thereof a herbicidally effective amount of a compound of formula (I) wherein A1, A2, A3, A4, R3, R4 and R5 are as defined in claim 1; or a salt or N-oxide thereof. Furthermore, the present invention relates to processes for preparing compounds of formula (I), to intermediates used in the preparation of compounds of formula (I), to herbicidal compositions comprising compounds of formula (I) and to certain novel pyridopyridines, pyridodiazines and pyridotriazines.
    Type: Application
    Filed: September 6, 2013
    Publication date: January 9, 2014
    Applicant: Syngenta Limited
    Inventors: Matthew Robert Cordingley, Michael Drysdale Turnbull, Nigel James Willetts, Patrick Jelf Crowley
  • Compounds
    Patent number: 8609657
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: October 2, 2012
    Date of Patent: December 17, 2013
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Charlotte Jane Mitchell, Nigel James Parr
  • Compounds
    Patent number: 8586583
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): And salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: October 2, 2012
    Date of Patent: November 19, 2013
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Nigel James Parr
  • Compounds
    Patent number: 8586590
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: October 2, 2012
    Date of Patent: November 19, 2013
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Nigel James Parr
  • EYE EXAMINATION SYSTEM
    Publication number: 20130301003
    Abstract: An eye examination system including a patient display visible by the patient during examination and an image capturing device arranged to take an image of the patient's eye during examination, the patient display being arranged to receive and display in real time the image for the patient to view during examination.
    Type: Application
    Filed: November 7, 2011
    Publication date: November 14, 2013
    Inventors: Anthony Philip Wells, Nigel James Sharplin
  • HERBICIDAL COMPOUNDS
    Publication number: 20130303370
    Abstract: The present invention provides a compound of formula (I) wherein R4 is of sub-formula (a) or (b) and wherein the other substituents are as defined in the specification. The compounds of formula (I) are potentially useful as herbicides.
    Type: Application
    Filed: October 14, 2011
    Publication date: November 14, 2013
    Applicants: SYNGENTA LIMITED, SYNGENTA PARTICIPATIONS AG
    Inventors: Alaric James Avery, Alain De Mesmaeker, Nicholas Phillip Mulholland, Nigel James Willetts, Paul Anthony Worthington
  • Compounds
    Patent number: 8580797
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: April 28, 2010
    Date of Patent: November 12, 2013
    Assignee: Glaxo Smith Kline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Nigel James Parr
  • Compounds
    Patent number: 8575162
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: April 28, 2010
    Date of Patent: November 5, 2013
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Charlotte Jane Mitchell, Nigel James Parr